Donate

Publication Details

Need to talk? Call us free*
0800 808 00 00 7 days a week, 8am-8pm
Other targeted drugs for lymphoma

Other targeted drugs for lymphoma (February 2020)

This factsheet is about some of the other targeted drugs approved for people with lymphoma. It explains what types of targeted drugs are available: radioimmunotherapy; cell signal blockers; proteasome inhibitors; and immunomodulators.

Author(s)
Lymphoma Action
Place of publication
Aylesbury
Publisher
Lymphoma Action
Date of publication
February 2020
Pages
6pp
Supplier
https://lymphoma-action.org.uk/
Subject(s)
Lymphomas, Targeted therapies, Radioimmunotherapy, Cell signal blockers, Proteasome inhibitors, Immunomodulatory drugs, Zevalin®, 90Y-Ibritumomab tiuxetan, Temsirolimus, Torisel®, Bortezomib, (Bortezomib Accord, Velcade®, Lenalidomide, Revlimid®
Format
Factsheet
Language
English
Flesch readability score
45.7
Download this resource
Download this resource
Back to results
Need to talk? Call us free*
0800 808 00 00 7 days a week, 8am-8pm
Donate

About this site

Macmillan sites

Right there with you

We're here to provide physical, financial and emotional support. So whatever cancer throws your way, we're right there with you. Contact us

Follow us

© Macmillan Cancer Support 2019 © Macmillan Cancer Support, registered charity in England and Wales (261017), Scotland (SC039907) and the Isle of Man (604). Also operating in Northern Ireland. A company limited by guarantee, registered in England and Wales company number 2400969. Isle of Man company number 4694F. Registered office: 89 Albert Embankment, London SE1 7UQ. VAT no: 668265007